Prevalence of Diabetic Retinopathy in Health Care Settings

David B. Rein,John S. Wittenborn

DOI: https://doi.org/10.1001/jamaophthalmol.2024.2124

IF: 8.253

2024-07-19

JAMA Ophthalmology

Abstract:Markle et al 1 evaluated 2015 through 2022 trends in prevalence of diabetic retinopathy (DR) diagnoses within a cohort of 814 253 patients with diagnosed diabetes who received medical care from 1 of the 56 US health care organizations who participate in the TriNetX platform. The most striking finding was the reported increase in the prevalence of DR in younger cohorts (aged 20-39 years) between 2015 and 2022. In patients with type 1 diabetes, Markle et al 1 reported a 4.7-fold increase in the prevalence of DR among those aged 20 to 29 years and a 1.96-fold increase among those aged 30 to 39 years. Patients 40 years or older with type 1 diabetes had smaller increases in prevalence of DR except for patients 70 or older for whom prevalence decreased. In patients with type 2 diabetes, prevalence of DR increased 2.5 times in those aged 20 to 29 years, 1.6 times in those aged 30 to 39 years, and 1.5 times in those aged 40 to 49 years. Patients aged 50 to 69 years had smaller increases in prevalence, but patients 70 years or older had a modest 0.9-fold decrease in DR prevalence.

ophthalmology